ホームヘルスケア市場規模、セグメント分析、2030年までの世界予測

このレポートでは、世界のホームヘルスケア市場を、製品（治療用製品、検査、スクリーニング、モニタリング用製品、移動ケア製品）、サービス（熟練看護サービス、リハビリテーション療法サービス、ホスピスおよび緩和ケアサービス、非熟練ケアサービス、呼吸療法サービス、輸液療法サービス、妊娠ケアサービス）、適応症（がん、呼吸器疾患、移動障害、心血管疾患および高血圧、妊娠、創傷ケア、糖尿病、聴覚障害、その他の適応症）、地域（北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東およびアフリカ、GCC諸国）といったさまざまな基準に基づいてセグメント化しています。

本レポートは、ホームヘルスケア市場の成長に影響を与える主要な推進要因、課題、機会、そして制約要因について詳細な分析を提供しています。また、主要プレーヤーの事業概要、サービスポートフォリオ、戦略的取り組み、買収、製品の発売・承認、事業拡大、そして在宅医療市場に関連する最近の動向など、詳細な評価を提供しています。さらに、在宅医療エコシステムにおける新興スタートアップ企業の競争動向についても考察しています。本レポートは、既存企業だけでなく新規参入企業や小規模企業も市場の動向を把握し、より大きな市場シェアを獲得することを可能にします。本レポートを購入した企業は、以下の戦略のいずれか、または組み合わせて活用することで、市場でのプレゼンスを強化することができます。

世界のホームヘルスケア市場は、予測期間中に年平均成長率8.9%で成長し、2025年の3,099億米ドルから2030年には4,738億米ドルに達すると予測されています。高血圧、肥満、心臓疾患といった生活習慣病の増加により、市場は拡大しており、在宅医療製品の需要が高まっています。さらに、世界的なリーディングカンパニーによる継続的なイノベーションと新製品ラインの導入も市場の成長に貢献しています。これらの企業は、在宅医療向けに特別に設計された幅広い先進技術を提供しています。

The global home healthcare market is projected to reach USD 473.8 billion by 2030 from USD 309.9 billion in 2025, at a CAGR of 8.9% during the forecast period.

The market is expanding due to a rise in lifestyle-related disorders such as high blood pressure, obesity, and cardiac conditions, which are driving greater demand for home healthcare products. Furthermore, ongoing innovation and the introduction of new product lines by leading global companies are contributing to market growth. These companies are offering a wide range of advanced technologies designed specifically for home healthcare.

The therapeutic products segment accounted for the largest share of the home healthcare market in 2024, by product.

The home healthcare market is categorized by type into therapeutic products, testing, screening, and monitoring devices, and mobility care devices. Therapeutic products accounted for the largest share. The strong growth in the therapeutic product segment is largely driven by the increasing number of people living with chronic health conditions such as diabetes, heart disease, and respiratory issues. As these long-term illnesses become more common, there is a growing demand for effective treatment solutions that can be used at home. This rising need for convenient and accessible care is fueling the expansion of the therapeutic product segment within the home healthcare market.

The skilled nursing services segment accounted for the largest market share of the home healthcare market, in 2024, by service.

The home healthcare market is segmented by service into skilled nursing services, rehabilitation therapy services, hospice & palliative care services, unskilled care services, respiratory therapy services, infusion therapy services, and pregnancy care services. Skilled nursing services hold a significant market share, mainly because of the rising number of patients who require professional medical care at home for chronic illnesses, post-surgery recovery, and age-related conditions. These services are provided by licensed nurses and include tasks such as administering medication, wound care, and monitoring vital signs. As the aging population grows and healthcare systems shift toward home-based care, the demand for skilled nursing services continues to rise, making it a key driver of growth in the home healthcare services market.

The Asia Pacific region is projected to witness the highest growth rate in the home healthcare market during the forecast period.

The global home healthcare market is divided into six key regions: North America, Europe, Latin America, Asia Pacific, the Middle East & Africa, and the GCC Countries. Among these, the Asia Pacific region, which includes countries like Japan, India, China, and others, is anticipated to present substantial growth opportunities and is projected to register the highest CAGR during the forecast period.

Several factors contribute to this growth in the Asia Pacific, including rising healthcare expenditures, increasing demand for affordable and accessible care, and a growing elderly population. Moreover, governments in the region are actively promoting home-based healthcare through supportive policies, funding initiatives, and infrastructure development. These efforts are aimed at reducing the burden on traditional healthcare facilities and improving healthcare access, thereby fueling the expansion of the home healthcare market in the Asia Pacific.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1–40%, Tier 2–50%, and Tier 3– 10%
• By Designation: C-level–48%, Director-level–37% and Others–15%
• By Region: North America–46%, Europe–26%, Asia Pacific–17%, Latin America- 7%, Middle East & Africa – 4% and GCC Countries – 1%

Note 1: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The major players operating in the home healthcare market are Fresenius Medical Care AG (Germany), Abbott (US), Linde plc (Ireland), F. Hoffmann-La Roche, Ltd (Switzerland), ResMed (US), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), A&D HOLON Holdings Company, Limited (Japan), Convatec Group PLC (UK), Amedisys (US), and OMRON Healthcare Co., Ltd. (Japan).

Research Coverage

This report segments the global home healthcare market based on various criteria: product (therapeutic products, testing, screening, and monitoring products, and mobility care products), service (skilled nursing services, rehabilitation therapy services, hospice & palliative care services, unskilled care services, respiratory therapy services, infusion therapy services and pregnancy care services), indication (cancer, respiratory diseases, mobility disorders, cardiovascular diseases & hypertension, pregnancy, wound care, diabetes, hearing disorders and other indications) and region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries).

The report provides an in-depth analysis of the key drivers, challenges, opportunities, and restraints influencing market growth. It also offers a detailed evaluation of leading industry players, covering their business profiles, service portfolios, strategic initiatives, acquisitions, product launches & approvals, expansions, and recent developments related to the home healthcare market. Furthermore, the report explores the competitive dynamics of emerging startups within the home healthcare ecosystem.

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the following strategies for strengthening their market presence.

This report provides insights on the following pointers:

• Analysis of key drivers (growing elderly population and rising incidence of chronic diseases, rapid technological advancements, need for cost-effective healthcare delivery, increased preference for personalized care), restraints (changing reimbursement policies, limited insurance coverage, patient safety concerns), opportunities (rising focus on telehealth, growing preference for home-based treatments) and challenges (shortage of home care workers, lack of supporting infrastructure)
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the home healthcare market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the home healthcare market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the home healthcare market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

Table of Contents

1               INTRODUCTION              28

1.1           STUDY OBJECTIVES       28

1.2           MARKET DEFINITION   28

1.3           MARKET SCOPE                29

1.3.1        MARKETS COVERED AND REGIONAL SCOPE      29

1.3.2        INCLUSIONS AND EXCLUSIONS 30

1.3.3        YEARS CONSIDERED      30

1.4           CURRENCY CONSIDERED            30

1.5           STAKEHOLDERS               31

1.6           SUMMARY OF CHANGES               31

2               RESEARCH METHODOLOGY       32

2.1           RESEARCH DATA              32

2.1.1        SECONDARY DATA          32

2.1.1.1    Key data from secondary sources       33

2.1.2        PRIMARY DATA 34

2.1.2.1    Primary sources    34

2.1.2.2    Key industry insights           35

2.1.2.3    Key data from primary sources           35

2.1.2.4    Breakdown of primary interviews      36

2.2           MARKET SIZE ESTIMATION         36

2.2.1        BOTTOM-UP APPROACH              37

2.2.1.1    Company revenue estimation approach            37

2.2.1.2    Presentations of companies and primary interviews       37

2.2.1.3    Primary interviews                38

2.2.1.4    Growth forecast    38

2.2.1.5    CAGR projections                 38

2.2.2        TOP-DOWN APPROACH                38

2.3           MARKET BREAKDOWN AND DATA TRIANGULATION                 39

2.4           RESEARCH ASSUMPTIONS           40

2.4.1        PARAMETRIC ASSUMPTIONS     40

2.4.2        GROWTH RATE ASSUMPTIONS 41

2.5           RESEARCH LIMITATIONS             42

2.6           RISK ANALYSIS  42

3               EXECUTIVE SUMMARY  43

4               PREMIUM INSIGHTS       47

4.1           HOME HEALTHCARE MARKET OVERVIEW           47

4.2           GEOGRAPHIC GROWTH OPPORTUNITIES            48

4.3           HOME HEALTHCARE MARKET: GEOGRAPHIC MIX                 49

4.4           HOME HEALTHCARE MARKET: DEVELOPED VS. DEVELOPING MARKETS                50

5               MARKET OVERVIEW       51

5.1           INTRODUCTION              51

5.2           MARKET DYNAMICS       51

5.2.1        DRIVERS               52

5.2.1.1    Growing elderly population and rising incidence of chronic diseases  52

5.2.1.2    Rapid technological advancements    53

5.2.1.3    Need for cost-effective healthcare delivery      54

5.2.1.4    Increased preference for personalized care      54

5.2.2        RESTRAINTS      55

5.2.2.1    Changing reimbursement policies     55

5.2.2.2    Limited insurance coverage                 56

5.2.2.3    Patient safety concerns        56

5.2.3        OPPORTUNITIES              57

5.2.3.1    Rising focus on telehealth   57

5.2.3.2    Growing preference for home-based treatments             57

5.2.4        CHALLENGES    58

5.2.4.1    Shortage of home care workers           58

5.2.4.2    Lack of supporting infrastructure      58

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            59

5.4           PRICING ANALYSIS          59

5.4.1        AVERAGE SELLING PRICE TREND, BY PRODUCT                 60

5.4.2        AVERAGE SELLING PRICE TREND, BY KEY PLAYER                 60

5.4.3        AVERAGE SELLING PRICE TREND, BY REGION   61

5.5           VALUE CHAIN ANALYSIS               62

5.6           SUPPLY CHAIN ANALYSIS             63

5.7           ECOSYSTEM ANALYSIS  64

5.8           INVESTMENT AND FUNDING SCENARIO               65

5.9           TECHNOLOGY ANALYSIS             66

5.9.1        KEY TECHNOLOGIES     66

5.9.1.1    Vital sign monitoring devices             66

5.9.1.2    Wearable devices  66

5.9.2        COMPLEMENTARY TECHNOLOGIES       66

5.9.2.1    Health data platforms          66

5.9.2.2    Medication management system        67

5.9.3        ADJACENT TECHNOLOGIES       67

5.9.3.1    Augmented Reality and Virtual Reality (AR/VR)           67

5.10         PATENT ANALYSIS          67

5.11         TRADE ANALYSIS             70

5.11.1      IMPORT DATA (HS CODE 901890)              70

5.11.2      EXPORT DATA (HS CODE 901890)              70

5.12         KEY CONFERENCES AND EVENTS, 2025–2026        71

5.13         REGULATORY LANDSCAPE         72

5.13.1      REGULATORY ANALYSIS               72

5.13.1.1  North America      72

5.13.1.1.1                US           72

5.13.1.1.2                Canada   73

5.13.1.2  Europe   74

5.13.1.3  Asia Pacific            75

5.13.1.3.1                Japan      75

5.13.1.3.2                China      76

5.13.1.3.3                India       77

5.13.2      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             78

5.14         PORTER’S FIVE FORCES ANALYSIS           80

5.14.1      BARGAINING POWER OF SUPPLIERS       81

5.14.2      BARGAINING POWER OF BUYERS             81

5.14.3      THREAT OF NEW ENTRANTS      81

5.14.4      THREAT OF SUBSTITUTES          82

5.14.5      INTENSITY OF COMPETITIVE RIVALRY 82

5.15         KEY STAKEHOLDERS AND BUYING CRITERIA     82

5.15.1      KEY STAKEHOLDERS IN BUYING PROCESS           82

5.15.2      BUYING CRITERIA           83

5.16         IMPACT OF AI ON HOME HEALTHCARE MARKET                 84

5.16.1      INTRODUCTION              84

5.16.2      MARKET POTENTIAL OF AI IN HOME HEALTHCARE MARKET               84

5.16.3      AI USE CASES     85

5.16.4      KEY COMPANIES IMPLEMENTING AI      86

5.16.5      FUTURE OF AI IN HOME HEALTHCARE MARKET                 86

5.17         ADJACENT MARKETS FOR HOME HEALTHCARE MARKET               86

5.18         IMPACT OF US TARIFF REGULATION ON HOME HEALTHCARE MARKET 87

5.18.1      INTRODUCTION              87

5.18.2      KEY TARIFF RATES          87

5.18.3      PRICE IMPACT ANALYSIS             88

5.18.4      KEY IMPACT ON COUNTRY/REGION      88

5.18.4.1  North America      88

5.18.4.2  Europe   89

5.18.4.3  Asia Pacific            89

5.18.5      IMPACT ON END-USE INDUSTRIES          89

5.18.5.1  Home healthcare providers 89

6               HOME HEALTHCARE MARKET, BY PRODUCT     90

6.1           INTRODUCTION              91

6.2           THERAPEUTIC PRODUCTS          91

6.2.1        DIALYSIS EQUIPMENT  93

6.2.1.1    Favorable reimbursement scenario for home dialysis to favor growth    93

6.2.2        WOUND CARE PRODUCTS           94

6.2.2.1    Rising geriatric population and subsequent incidence of chronic diseases to amplify growth  94

6.2.3        IV EQUIPMENT 95

6.2.3.1    Technological advancements in IV therapy to contribute to growth    95

6.2.4        SLEEP APNEA THERAPEUTIC DEVICES  96

6.2.4.1    Increasing patient preference for home-based sleep tests to bolster growth       96

6.2.5        INSULIN DELIVERY DEVICES      97

6.2.5.1    High incidence of diabetes to favor growth      97

6.2.6        OXYGEN DELIVERY SYSTEMS     98

6.2.6.1    Growing trend of using oxygen therapy for respiratory disorders to propel market   98

6.2.7        INHALERS            99

6.2.7.1    High incidence of asthma to stimulate growth 99

6.2.8        NEBULIZERS      100

6.2.8.1    Faster relief and longer symptom control to accelerate growth                 100

6.2.9        VENTILATORS  101

6.2.9.1    Growing use of positive airway pressure devices for sleep apnea therapy to drive market       101

6.2.10      OTHER THERAPEUTIC PRODUCTS          102

6.3           TESTING, SCREENING, AND MONITORING PRODUCTS                 103

6.3.1        BLOOD GLUCOSE MONITORS   107

6.3.1.1    Increasing preference for self-diagnosis to contribute to growth                 107

6.3.2        HEARING AIDS  108

6.3.2.1    High incidence of hearing impairment to augment growth                 108

6.3.3        ACTIVITY MONITORS & WRISTBANDS   109

6.3.3.1    Increasing awareness about health and fitness to sustain growth                 109

6.3.4        ECG/EKG DEVICES          109

6.3.4.1    High prevalence of cardiovascular diseases to support growth                 109

6.3.5        TEMPERATURE MONITORING DEVICES                110

6.3.5.1    Rising use of digital thermometers for quick and accurate results to aid growth         110

6.3.6        HEART RATE MONITORS              111

6.3.6.1    Need for real-time monitoring to advance growth          111

6.3.7        PULSE OXIMETERS          112

6.3.7.1    Rising disease incidence and wide usage of pulse oximetry to promote growth    112

6.3.8        OVULATION & PREGNANCY TEST KITS 113

6.3.8.1    Privacy, convenience, accessibility, and quick results to facilitate growth    113

6.3.9        BLOOD PRESSURE MONITORS  114

6.3.9.1    Growing integration of pressure monitoring devices with digital health platforms to boost market       114

6.3.10      HIV TEST KITS  116

6.3.10.1  Increasing number of HIV-infected individuals globally to favor growth    116

6.3.11      FETAL MONITORING DEVICES  117

6.3.11.1  Increasing reliance on remote-based care to promote growth                 117

6.3.12      HOLTER & EVENT MONITORS   118

6.3.12.1  Portability and storage attributes to aid growth               118

6.3.13      DRUG & ALCOHOL TEST KITS   119

6.3.13.1  Rise in drug abuse and alcohol consumption to support growth                 119

6.3.14      COAGULATION MONITORING PRODUCTS          120

6.3.14.1  Rising incidence of deep vein thrombosis, pulmonary embolism, and hemophilia to foster growth        120

6.3.15      PEAK FLOW METERS      121

6.3.15.1  High portability and cost-efficiency to increase adoption                 121

6.3.16      COLON CANCER TEST KITS        122

6.3.16.1  High incidence of colorectal cancer to drive market       122

6.3.17      EEG DEVICES     123

6.3.17.1  Wide patient population for epilepsy to fuel market       123

6.3.18      HOME SLEEP TESTING DEVICES               124

6.3.18.1  Need for specialized care at home to spur growth           124

6.3.19      CHOLESTEROL TESTING PRODUCTS     125

6.3.19.1  Rising obesity levels and cardiovascular incidence to augment growth    125

6.3.20      HOME HBA1C TEST KITS              126

6.3.20.1  Increasing recommendations for regular testing and favorable clinical outcomes to aid growth          126

6.4           MOBILITY CARE PRODUCTS       127

6.4.1        WHEELCHAIRS  129

6.4.1.1    Need for patient mobility with less pain and fatigue to fuel market                 129

6.4.2        MOBILITY SCOOTERS    130

6.4.2.1    Increasing demand for mobility-assisted devices to facilitate growth    130

6.4.3        WALKERS & ROLLATORS               131

6.4.3.1    Rising prevalence for gait disorders, osteoarthritis, and other degenerative joint diseases to aid growth         131

6.4.4        CRUTCHES          132

6.4.4.1    Increasing use of crutches during post-operative recovery to boost market          132

6.4.5        CANES  133

6.4.5.1    Low cost, ease of use, and wide availability to contribute to growth    133

7               HOME HEALTHCARE MARKET, BY SERVICE         135

7.1           INTRODUCTION              136

7.2           SKILLED NURSING SERVICES      138

7.2.1        NEED FOR SPECIFIC PLAN OF CARE TO PROMOTE GROWTH             138

7.3           REHABILITATION THERAPY SERVICES  139

7.3.1        RISING DEMAND FOR IN-HOME CARE PERSONNEL TO STIMULATE GROWTH   139

7.4           HOSPICE & PALLIATIVE CARE SERVICES                140

7.4.1        INCREASING GERIATRIC POPULATION TO FACILITATE GROWTH             140

7.5           UNSKILLED CARE SERVICES       141

7.5.1        HIGHER AFFORDABILITY THAN HOSPITAL OR NURSING HOME SERVICES TO AID GROWTH          141

7.6           RESPIRATORY THERAPY SERVICES          142

7.6.1        GROWING PREVALENCE OF RESPIRATORY DISORDERS TO DRIVE MARKET         142

7.7           INFUSION THERAPY SERVICES  143

7.7.1        SAFE AND EFFECTIVE ALTERNATIVE TO INPATIENT CARE TO ENCOURAGE GROWTH              143

7.8           PREGNANCY CARE SERVICES     144

7.8.1        NEED FOR BETTER MANAGEMENT OF HIGH-RISK PREGNANCIES AND COMPLICATIONS TO ENSURE GROWTH                 144

8               HOME HEALTHCARE MARKET, BY INDICATION                 146

8.1           INTRODUCTION              147

8.2           CANCER                148

8.2.1        INCREASING PREFERENCE FOR AT-HOME TREATMENT TO EXPEDITE GROWTH                148

8.3           RESPIRATORY DISEASES               149

8.3.1        RISING INCIDENCE OF CHRONIC DISEASES TO SUSTAIN GROWTH             149

8.4           MOBILITY DISORDERS  150

8.4.1        GROWING GERIATRIC POPULATION TO BOOST MARKET               150

8.5           PREGNANCY      151

8.5.1        RISING FOCUS ON BETTER CARE AND MONITORING DURING PREGNANCY TO AID GROWTH                151

8.6           CARDIOVASCULAR DISEASES & HYPERTENSION                 152

8.6.1        GROWING HEALTH AWARENESS TO DRIVE MARKET                 152

8.7           WOUND CARE   153

8.7.1        INCREASING NUMBER OF ROAD ACCIDENTS AND TRAUMA INJURIES TO BOLSTER GROWTH           153

8.8           DIABETES           154

8.8.1        SHIFT IN CONSUMER PREFERENCE FROM TRADITIONAL TO MULTIFUNCTIONAL BLOOD GLUCOSE METERS TO SPUR GROWTH        154

8.9           HEARING DISORDERS   155

8.9.1        WORLDWIDE INCREASE IN HEARING DISABILITIES TO FOSTER GROWTH            155

8.10         OTHER INDICATIONS   156

9               HOME HEALTHCARE MARKET, BY REGION          158

9.1           INTRODUCTION              159

9.2           NORTH AMERICA             160

9.2.1        MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 161

9.2.2        US           166

9.2.2.1    Significant demographic change to contribute to growth                 166

9.2.3        CANADA               171

9.2.3.1    Growing elderly population to drive market    171

9.3           EUROPE               176

9.3.1        MACROECONOMIC OUTLOOK FOR EUROPE      177

9.3.2        GERMANY           182

9.3.2.1    Increasing demand for healthcare services to bolster growth                 182

9.3.3        UK          187

9.3.3.1    Aging population and rising patient pool to expedite growth                 187

9.3.4        FRANCE                192

9.3.4.1    Favorable government support to boost market              192

9.3.5        ITALY    197

9.3.5.1    Universal eligibility for home care to favor growth         197

9.3.6        SPAIN    202

9.3.6.1    Upsurge in elderly population to accelerate growth        202

9.3.7        REST OF EUROPE             207

9.4           ASIA PACIFIC     212

9.4.1        MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 213

9.4.2        JAPAN   219

9.4.2.1    High life expectancy and growing healthcare innovations to fuel market    219

9.4.3        CHINA  224

9.4.3.1    Increasing cases of diabetes and diabetic foot ulcers to favor growth    224

9.4.4        INDIA    229

9.4.4.1    Rising disposable income and focus on personalized care to spur growth    229

9.4.5        REST OF ASIA PACIFIC   234

9.5           LATIN AMERICA                239

9.5.1        RISING HEALTHCARE NEEDS TO AID GROWTH 239

9.5.2        MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 240

9.6           MIDDLE EAST & AFRICA                245

9.6.1        GROWING INVESTMENTS IN HEALTHCARE INFRASTRUCTURE TO PROPEL MARKET               245

9.6.2        MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 246

9.7           GCC COUNTRIES              251

9.7.1        DIGITAL TRANSFORMATION AND EXPANDING PUBLIC-PRIVATE PARTNERSHIPS TO FUEL MARKET        251

9.7.2        MACROECONOMIC OUTLOOK FOR GCC COUNTRIES                 252

10            COMPETITIVE LANDSCAPE         258

10.1         OVERVIEW          258

10.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            258

10.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS                 259

10.3         REVENUE ANALYSIS, 2022–2024  262

10.4         MARKET SHARE ANALYSIS, 2024                 262

10.5         COMPANY VALUATION AND FINANCIAL METRICS                 265

10.6         BRAND/PRODUCT COMPARISON             266

10.7         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 266

10.7.1      STARS   266

10.7.2      EMERGING LEADERS     267

10.7.3      PERVASIVE PLAYERS      267

10.7.4      PARTICIPANTS 267

10.7.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         268

10.7.5.1  Company footprint               268

10.7.5.2  Region footprint   269

10.7.5.3  Product & service footprint 270

10.7.5.4  Product footprint  270

10.7.5.5  End-user footprint                271

10.8         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        272

10.8.1      PROGRESSIVE COMPANIES         272

10.8.2      RESPONSIVE COMPANIES            272

10.8.3      DYNAMIC COMPANIES  272

10.8.4      STARTING BLOCKS         272

10.8.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 274

10.8.5.1  Detailed list of key startups/SMEs    274

10.8.5.2  Competitive benchmarking of key startups/SMEs          275

10.9         COMPETITIVE SCENARIO             275

10.9.1      PRODUCT LAUNCHES AND APPROVALS               275

10.9.2      DEALS  277

10.9.3      EXPANSIONS     279

11            COMPANY PROFILES      280

11.1         KEY PLAYERS     280

11.1.1      FRESENIUS MEDICAL CARE AG  280

11.1.1.1  Business overview 280

11.1.1.2  Products/Solutions/Services offered 281

11.1.1.3  Recent developments           282

11.1.1.3.1                Product launches and approvals         282

11.1.1.3.2                Deals      283

11.1.1.3.3                Expansions             283

11.1.1.4  MnM view              283

11.1.1.4.1                Key strengths        283

11.1.1.4.2                Strategic choices   284

11.1.1.4.3                Weaknesses and competitive threats 284

11.1.2      ABBOTT               285

11.1.2.1  Business overview 285

11.1.2.2  Products/Solutions/Services offered 287

11.1.2.3  Recent developments           288

11.1.2.3.1                Product launches and approvals         288

11.1.2.3.2                Deals      288

11.1.2.3.3                Expansions             289

11.1.2.4  MnM view              289

11.1.2.4.1                Key strengths        289

11.1.2.4.2                Strategic choices   289

11.1.2.4.3                Weaknesses and competitive threats 289

11.1.3      LINDE PLC          290

11.1.3.1  Business overview 290

11.1.3.2  Products/Solutions/Services offered 291

11.1.3.3  MnM view              292

11.1.3.3.1                Key strengths        292

11.1.3.3.2                Strategic choices   292

11.1.3.3.3                Weaknesses and competitive threats 292

11.1.4      F. HOFFMANN-LA ROCHE LTD  293

11.1.4.1  Business overview 293

11.1.4.2  Products/Solutions/Services offered 294

11.1.4.3  Recent developments           294

11.1.4.3.1                Product launches and approvals         294

11.1.4.4  MnM view              295

11.1.4.4.1                Key strengths        295

11.1.4.4.2                Strategic choices   295

11.1.4.4.3                Weaknesses and competitive threats 295

11.1.5      RESMED               296

11.1.5.1  Business overview 296

11.1.5.2  Products/Solutions/Services offered 297

11.1.5.3  Recent developments           298

11.1.5.3.1                Product launches and approvals         298

11.1.5.3.2                Deals      299

11.1.5.4  MnM view              299

11.1.5.4.1                Key strengths        299

11.1.5.4.2                Strategic choices   299

11.1.5.4.3                Weaknesses and competitive threats 299

11.1.6      KONINKLIJKE PHILIPS N.V.          300

11.1.6.1  Business overview 300

11.1.6.2  Products/Solutions/Services offered 301

11.1.6.3  Recent developments           303

11.1.6.3.1                Product launches and approvals         303

11.1.6.3.2                Deals      304

11.1.7      GE HEALTHCARE             305

11.1.7.1  Business overview 305

11.1.7.2  Products/Solutions/Services offered 306

11.1.7.3  Recent developments           308

11.1.7.3.1                Deals      308

11.1.8      A&D HOLON HOLDINGS COMPANY, LIMITED   309

11.1.8.1  Business overview 309

11.1.8.2  Products/Solutions/Services offered 310

11.1.9      CONVATEC GROUP PLC                312

11.1.9.1  Business overview 312

11.1.9.2  Products/Solutions/Services offered 313

11.1.9.3  Recent developments           314

11.1.9.3.1                Product launches and approvals         314

11.1.9.4  Recent developments           314

11.1.9.4.1                Expansions             315

11.1.10   AMEDISYS           316

11.1.10.1                 Business overview 316

11.1.10.2                 Products/solutions/services offered  317

11.1.10.3                 Recent developments           318

11.1.10.3.1             Deals      318

11.1.11   OMRON HEALTHCARE CO., LTD.              320

11.1.11.1                 Business overview 320

11.1.11.2                 Products/Solutions/Services offered 322

11.1.11.3                 Recent developments           324

11.1.11.3.1             Deals      324

11.2         OTHER PLAYERS              325

11.2.1      INVACARE CORPORATION          325

11.2.2      BAYADA HOME HEALTH CARE  326

11.2.3      DRIVE DEVILBISS HEALTHCARE                327

11.2.4      SUNRISE MEDICAL          328

11.2.5      ROMA MEDICAL               330

11.2.6      CAREMAX REHABILITATION EQUIPMENT CO., LTD.                 332

11.2.7      VITALOGRAPH 333

11.2.8      ADVITA PFLEGEDIENST GMBH 334

11.2.9      THE RENAFAN GROUP  335

11.2.10   CONTEC MEDICAL SYSTEMS CO., LTD. 336

11.2.11   B. BRAUN SE       337

11.2.12   BAXTER                338

11.2.13   MEDLINE INDUSTRIES  339

11.2.14   ADVIN HEALTH CARE    340

12            APPENDIX           341

12.1         DISCUSSION GUIDE        341

12.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                346

12.3         CUSTOMIZATION OPTIONS        348

12.4         RELATED REPORTS         348

12.5         AUTHOR DETAILS           349

LIST OF TABLES

TABLE 1                HOME HEALTHCARE MARKET: INCLUSIONS AND EXCLUSIONS           30

TABLE 2                HOME HEALTHCARE MARKET: RISK ANALYSIS                 42

TABLE 3                GERIATRIC POPULATION, 2022 VS. 2050 (MILLION)           52

TABLE 4                PRODUCT LAUNCHES BY KEY PLAYERS, 2022–2024        53

TABLE 5                AVERAGE SELLING PRICING TREND OF HOME HEALTHCARE PRODUCTS,

BY TYPE, 2023–2025 (USD)            60

TABLE 6                AVERAGE SELLING PRICE TREND OF HOME HEALTHCARE PRODUCTS,

BY KEY PLAYER, 2023–2025 (USD)              60

TABLE 7                AVERAGE SELLING PRICE TREND OF HOME HEALTHCARE PRODUCTS,

BY REGION, 2023–2025 (USD)      61

TABLE 8                HOME HEALTHCARE MARKET: ROLE OF COMPANIES IN ECOSYSTEM       64

TABLE 9                HOME HEALTHCARE MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2024       69

TABLE 10              IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD MILLION)     70

TABLE 11              EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD MILLION)     70

TABLE 12              HOME HEALTHCARE MARKET: KEY CONFERENCES AND EVENTS, 2025–2026                 71

TABLE 13              US FDA: CLASSIFICATION OF MEDICAL DEVICES                 72

TABLE 14              US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS              73

TABLE 15              CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS      73

TABLE 16              JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES             75

TABLE 17              CHINA: CLASSIFICATION OF MEDICAL DEVICES                 76

TABLE 18              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  78

TABLE 19              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  78

TABLE 20              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  79

TABLE 21              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  79

TABLE 22              REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  80

TABLE 23              HOME HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS           81

TABLE 24              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF HOME HEALTHCARE PRODUCTS (%)           83

TABLE 25              KEY BUYING CRITERIA FOR HOME HEALTHCARE PRODUCTS            83

TABLE 26              US ADJUSTED RECIPROCAL TARIFF RATES                 87

TABLE 27              HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            91

TABLE 28              KEY THERAPEUTIC PRODUCTS OFFERED                 92

TABLE 29              HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE,

2023–2030 (USD MILLION)            92

TABLE 30              HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY REGION,

2023–2030 (USD MILLION)          93

TABLE 31              HOME HEALTHCARE MARKET FOR DIALYSIS EQUIPMENT, BY REGION,

2023–2030 (USD MILLION)            94

TABLE 32              HOME HEALTHCARE MARKET FOR WOUND CARE PRODUCTS, BY REGION,

2023–2030 (USD MILLION)            95

TABLE 33              HOME HEALTHCARE MARKET FOR IV EQUIPMENT, BY REGION,

2023–2030 (USD MILLION)            96

TABLE 34              HOME HEALTHCARE MARKET FOR SLEEP APNEA THERAPEUTIC DEVICES,

BY REGION, 2023–2030 (USD MILLION)   97

TABLE 35              HOME HEALTHCARE MARKET FOR INSULIN DELIVERY DEVICES, BY REGION, 2023–2030 (USD MILLION)                 98

TABLE 36              HOME HEALTHCARE MARKET FOR OXYGEN DELIVERY SYSTEMS, BY REGION, 2023–2030 (USD MILLION)                 99

TABLE 37              HOME HEALTHCARE MARKET FOR INHALERS, BY REGION,

2023–2030 (USD MILLION)            100

TABLE 38             HOME HEALTHCARE MARKET FOR NEBULIZERS, BY REGION,

2023–2030 (USD MILLION)          101

TABLE 39              HOME HEALTHCARE MARKET FOR VENTILATORS, BY REGION,

2023–2030 (USD MILLION)            102

TABLE 40              HOME HEALTHCARE MARKET FOR OTHER THERAPEUTIC PRODUCTS,

BY REGION, 2023–2030 (USD MILLION)   103

TABLE 41              KEY TESTING, SCREENING, AND MONITORING PRODUCTS OFFERED

BY MAJOR COMPANIES 103

TABLE 42              HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)            105

TABLE 43              HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2023–2030 (MILLION UNITS)        106

TABLE 44              HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)          106

TABLE 45              HOME HEALTHCARE MARKET FOR BLOOD GLUCOSE MONITORS, BY REGION, 2023–2030 (USD MILLION)                 107

TABLE 46              HOME HEALTHCARE MARKET FOR HEARING AIDS, BY REGION,

2023–2030 (USD MILLION)            108

TABLE 47              HOME HEALTHCARE MARKET FOR ACTIVITY MONITORS & WRISTBANDS,

BY REGION, 2023–2030 (USD MILLION)   109

TABLE 48              HOME HEALTHCARE MARKET FOR ECG/EKG DEVICES, BY REGION,

2023–2030 (USD MILLION)            110

TABLE 49              HOME HEALTHCARE MARKET FOR TEMPERATURE MONITORING DEVICES,

BY REGION, 2023–2030 (USD MILLION)   111

TABLE 50              HOME HEALTHCARE MARKET FOR HEART RATE MONITORS, BY REGION,

2023–2030 (USD MILLION)            112

TABLE 51              KEY INNOVATIONS IN PULSE OXIMETERS BY MAJOR COMPANIES        112

TABLE 52              HOME HEALTHCARE MARKET FOR PULSE OXIMETERS, BY REGION,

2023–2030 (USD MILLION)            113

TABLE 53              HOME HEALTHCARE MARKET FOR OVULATION & PREGNANCY TEST KITS,

BY REGION, 2023–2030 (USD MILLION)   114

TABLE 54              HOME HEALTHCARE MARKET FOR BLOOD PRESSURE MONITORS, BY REGION, 2023–2030 (USD MILLION)                 115

TABLE 55              NUMBER OF PEOPLE LIVING WITH HIV VS. NEW HIV CASES, BY REGION, 2023       116

TABLE 56              HOME HEALTHCARE MARKET FOR HIV TEST KITS, BY REGION,

2023–2030 (USD MILLION)            117

TABLE 57              HOME HEALTHCARE MARKET FOR FETAL MONITORING DEVICES, BY REGION, 2023–2030 (USD MILLION)                 118

TABLE 58              HOME HEALTHCARE MARKET FOR HOLTER & EVENT MONITORS, BY REGION, 2023–2030 (USD MILLION)                 119

TABLE 59              HOME HEALTHCARE MARKET FOR DRUG & ALCOHOL TEST KITS, BY REGION, 2023–2030 (USD MILLION)                 120

TABLE 60              HOME HEALTHCARE MARKET FOR COAGULATION MONITORING PRODUCTS,

BY REGION, 2023–2030 (USD MILLION)   121

TABLE 61              HOME HEALTHCARE MARKET FOR PEAK FLOW METERS, BY REGION,

2023–2030 (USD MILLION)            122

TABLE 62              HOME HEALTHCARE MARKET FOR COLON CANCER TEST KITS, BY REGION,

2023–2030 (USD MILLION)            123

TABLE 63              HOME HEALTHCARE MARKET FOR EEG DEVICES, BY REGION,

2023–2030 (USD MILLION)            124

TABLE 64              HOME HEALTHCARE MARKET FOR HOME SLEEP TESTING DEVICES,

BY REGION, 2023–2030 (USD MILLION)   125

TABLE 65              HOME HEALTHCARE MARKET FOR CHOLESTEROL TESTING PRODUCTS,

BY REGION, 2023–2030 (USD MILLION)   126

TABLE 66              HOME HEALTHCARE MARKET FOR HOME HBA1C TEST KITS, BY REGION,

2023–2030 (USD MILLION)            127

TABLE 67              KEY MOBILITY CARE PRODUCTS OFFERED BY MAJOR PLAYERS               127

TABLE 68              HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE,

2023–2030 (USD MILLION)            128

TABLE 69              HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY REGION,

2023–2030 (USD MILLION)            129

TABLE 70              HOME HEALTHCARE MARKET FOR WHEELCHAIRS, BY REGION,

2023–2030 (USD MILLION)            130

TABLE 71              HOME HEALTHCARE MARKET FOR MOBILITY SCOOTERS, BY REGION,

2023–2030 (USD MILLION)            131

TABLE 72              HOME HEALTHCARE MARKET FOR WALKERS & ROLLATORS, BY REGION,

2023–2030 (USD MILLION)            132

TABLE 73              HOME HEALTHCARE MARKET FOR CRUTCHES, BY REGION,

2023–2030 (USD MILLION)            133

TABLE 74              HOME HEALTHCARE MARKET FOR CANES, BY REGION, 2023–2030 (USD MILLION)          134

TABLE 75              HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                137

TABLE 76              HOME HEALTHCARE SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)          137

TABLE 77              HOME HEALTHCARE MARKET FOR SKILLED NURSING SERVICES, BY REGION, 2023–2030 (USD MILLION)                 138

TABLE 78              HOME HEALTHCARE MARKET FOR REHABILITATION THERAPY SERVICES,

BY REGION, 2023–2030 (USD MILLION)   139

TABLE 79              HOME HEALTHCARE MARKET FOR HOSPICE & PALLIATIVE CARE SERVICES,

BY REGION, 2023–2030 (USD MILLION)   140

TABLE 80              HOME HEALTHCARE MARKET FOR UNSKILLED SERVICES, BY REGION,

2023–2030 (USD MILLION)            141

TABLE 81              HOME HEALTHCARE MARKET FOR RESPIRATORY THERAPY SERVICES,

BY REGION, 2023–2030 (USD MILLION)   143

TABLE 82              HOME HEALTHCARE MARKET FOR INFUSION THERAPY SERVICES,

BY REGION, 2023–2030 (USD MILLION)   144

TABLE 83              HOME HEALTHCARE MARKET FOR PREGNANCY CARE SERVICES,

BY REGION, 2023–2030 (USD MILLION)   145

TABLE 84              HOME HEALTHCARE INDICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)         147

TABLE 85              HOME HEALTHCARE INDICATIONS MARKET, BY REGION,

2023–2030 (USD MILLION)            148

TABLE 86              INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)                149

TABLE 87              HOME HEALTHCARE MARKET FOR CANCER, BY REGION,

2023–2030 (USD MILLION)            149

TABLE 88              HOME HEALTHCARE MARKET FOR RESPIRATORY DISEASES, BY REGION,

2023–2030 (USD MILLION)            150

TABLE 89              HOME HEALTHCARE MARKET FOR MOBILITY DISORDERS, BY REGION,

2023–2030 (USD MILLION)            151

TABLE 90             HOME HEALTHCARE MARKET FOR PREGNANCY, BY REGION,

2023–2030 (USD MILLION)            152

TABLE 91              HOME HEALTHCARE MARKET FOR CARDIOVASCULAR DISEASES & HYPERTENSION, BY REGION, 2023–2030 (USD MILLION)            153

TABLE 92              HOME HEALTHCARE MARKET FOR WOUND CARE, BY REGION,

2023–2030 (USD MILLION)            154

TABLE 93              HOME HEALTHCARE MARKET FOR DIABETES, BY REGION,

2023–2030 (USD MILLION)            155

TABLE 94              HOME HEALTHCARE MARKET FOR HEARING DISORDERS, BY REGION,

2023–2030 (USD MILLION)            156

TABLE 95              HOME HEALTHCARE MARKET FOR OTHER INDICATIONS, BY REGION,

2023–2030 (USD MILLION)            157

TABLE 96              HOME HEALTHCARE MARKET, BY REGION, 2023–2030 (USD MILLION)            159

TABLE 97              NORTH AMERICA: KEY MACROECONOMIC INDICATORS      161

TABLE 98              NORTH AMERICA: HOME HEALTHCARE MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            161

TABLE 99              NORTH AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            162

TABLE 100            NORTH AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            162

TABLE 101            NORTH AMERICA: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS,

BY TYPE, 2023–2030 (USD MILLION)         163

TABLE 102            NORTH AMERICA: HOME HEALTHCARE MARKET FOR TESTING, SCREENING,

AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)            164

TABLE 103            NORTH AMERICA: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 165

TABLE 104            NORTH AMERICA: HOME HEALTHCARE SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            165

TABLE 105            NORTH AMERICA: HOME HEALTHCARE INDICATIONS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         166

TABLE 106            US: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            167

TABLE 107            US: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     168

TABLE 108            US: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE,

2023–2030 (USD MILLION)            168

TABLE 109          US: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)       169

TABLE 110            US: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)            170

TABLE 111            US: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                170

TABLE 112            US: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE,

2023–2030 (USD MILLION)            171

TABLE 113            CANADA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            172

TABLE 114            CANADA: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     173

TABLE 115            CANADA: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)                 173

TABLE 116            CANADA: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)            174

TABLE 117            CANADA: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS,

BY TYPE, 2023–2030 (USD MILLION)         175

TABLE 118            CANADA: HOME HEALTHCARE SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            175

TABLE 119            CANADA: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE,

2023–2030 (USD MILLION)            176

TABLE 120            EUROPE: KEY MACROECONOMIC INDICATORS                 177

TABLE 121            EUROPE: HOME HEALTHCARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     177

TABLE 122            EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            178

TABLE 123            EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     178

TABLE 124            EUROPE: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)                 179

TABLE 125            EUROPE: HOME HEALTHCARE MARKET FOR TESTING, SCREENING,

AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)            180

TABLE 126            EUROPE: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS,

BY TYPE, 2023–2030 (USD MILLION)         181

TABLE 127            EUROPE: HOME HEALTHCARE SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            181

TABLE 128            EUROPE: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE,

2023–2030 (USD MILLION)            182

TABLE 129            GERMANY: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            183

TABLE 130            GERMANY: HOME HEALTHCARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            183

TABLE 131            GERMANY: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)                 184

TABLE 132            GERMANY: HOME HEALTHCARE MARKET FOR TESTING, SCREENING,

AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)            185

TABLE 133            GERMANY: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS,

BY TYPE, 2023–2030 (USD MILLION)         186

TABLE 134            GERMANY: HOME HEALTHCARE SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            186

TABLE 135            GERMANY: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE,

2023–2030 (USD MILLION)            187

TABLE 136            UK: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            188

TABLE 137            UK: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     188

TABLE 138            UK: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE,

2023–2030 (USD MILLION)            189

TABLE 139            UK: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)            190

TABLE 140            UK: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)            191

TABLE 141            UK: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                191

TABLE 142            UK: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE,

2023–2030 (USD MILLION)            192

TABLE 143            FRANCE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            193

TABLE 144            FRANCE: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     193

TABLE 145            FRANCE: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)                 194

TABLE 146            FRANCE: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)            195

TABLE 147            FRANCE: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)            196

TABLE 148            FRANCE: HOME HEALTHCARE SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            196

TABLE 149            FRANCE: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE,

2023–2030 (USD MILLION)            197

TABLE 150            ITALY: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            198

TABLE 151            ITALY: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     198

TABLE 152            ITALY: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)                 199

TABLE 153            ITALY: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)            200

TABLE 154            ITALY: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS,

BY TYPE, 2023–2030 (USD MILLION)         201

TABLE 155            ITALY: HOME HEALTHCARE SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            201

TABLE 156            ITALY: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE,

2023–2030 (USD MILLION)            202

TABLE 157            SPAIN: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            203

TABLE 158            SPAIN: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     203

TABLE 159            SPAIN: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)                 204

TABLE 160            SPAIN: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)            205

TABLE 161            SPAIN: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)            206

TABLE 162            SPAIN: HOME HEALTHCARE SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            206

TABLE 163            SPAIN: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE,

2023–2030 (USD MILLION)            207

TABLE 164            REST OF EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            208

TABLE 165            REST OF EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            208

TABLE 166            REST OF EUROPE: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS,

BY TYPE, 2023–2030 (USD MILLION)         209

TABLE 167            REST OF EUROPE: HOME HEALTHCARE MARKET FOR TESTING, SCREENING,

AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)            210

TABLE 168            REST OF EUROPE: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 211

TABLE 169            REST OF EUROPE: HOME HEALTHCARE SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            211

TABLE 170            REST OF EUROPE: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE,

2023–2030 (USD MILLION)            212

TABLE 171            ASIA PACIFIC: KEY MACROECONOMIC INDICATORS      213

TABLE 172            ASIA PACIFIC: HOME HEALTHCARE MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            215

TABLE 173            ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            215

TABLE 174            ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            215

TABLE 175            ASIA PACIFIC: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS,

BY TYPE, 2023–2030 (USD MILLION)         216

TABLE 176            ASIA PACIFIC: HOME HEALTHCARE MARKET FOR TESTING, SCREENING,

AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)            217

TABLE 177            ASIA PACIFIC: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS,

BY TYPE, 2023–2030 (USD MILLION)         218

TABLE 178            ASIA PACIFIC: HOME HEALTHCARE SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            218

TABLE 179            ASIA PACIFIC: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE,

2023–2030 (USD MILLION)            219

TABLE 180            JAPAN: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            220

TABLE 181            JAPAN: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     220

TABLE 182            JAPAN: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)                 221

TABLE 183            JAPAN: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)            222

TABLE 184            JAPAN: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS,

BY TYPE, 2023–2030 (USD MILLION)         223

TABLE 185          JAPAN: HOME HEALTHCARE SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            223

TABLE 186            JAPAN: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE,

2023–2030 (USD MILLION)            224

TABLE 187            CHINA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            225

TABLE 188            CHINA: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     226

TABLE 189            CHINA: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)                 226

TABLE 190            CHINA: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)            227

TABLE 191            CHINA: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)            228

TABLE 192          CHINA: HOME HEALTHCARE SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            228

TABLE 193            CHINA: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE,

2023–2030 (USD MILLION)            229

TABLE 194            INDIA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD BILLION)             230

TABLE 195            INDIA: HOME HEALTHCARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     230

TABLE 196            INDIA: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)                 231

TABLE 197            INDIA: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)            232

TABLE 198            INDIA: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS,

BY TYPE, 2023–2030 (USD MILLION)         233

TABLE 199            INDIA: HOME HEALTHCARE SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            233

TABLE 200            INDIA: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE,

2023–2030 (USD MILLION)            234

TABLE 201            REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD BILLION)                 235

TABLE 202            REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            236

TABLE 203            REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 236

TABLE 204            REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)                237

TABLE 205            REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 238

TABLE 206            REST OF ASIA PACIFIC: HOME HEALTHCARE SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            238

TABLE 207            REST OF ASIA PACIFIC: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 239

TABLE 208            LATIN AMERICA: KEY MACROECONOMIC INDICATORS      240

TABLE 209            LATIN AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD BILLION)             241

TABLE 210            LATIN AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            241

TABLE 211            LATIN AMERICA: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS,

BY TYPE, 2023–2030 (USD MILLION)         242

TABLE 212            LATIN AMERICA: HOME HEALTHCARE MARKET FOR TESTING, SCREENING,

AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)            243

TABLE 213            LATIN AMERICA: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS,

BY TYPE, 2023–2030 (USD MILLION)         244

TABLE 214            LATIN AMERICA: HOME HEALTHCARE SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            244

TABLE 215            LATIN AMERICA: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE,

2023–2030 (USD MILLION)            245

TABLE 216            MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS              247

TABLE 217            MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD BILLION)                 247

TABLE 218            MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            247

TABLE 219            MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 248

TABLE 220            MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)                249

TABLE 221            MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 250

TABLE 222            MIDDLE EAST & AFRICA: HOME HEALTHCARE SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            250

TABLE 223            MIDDLE EAST & AFRICA: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 251

TABLE 224            GCC COUNTRIES: KEY MACROECONOMIC INDICATORS      253

TABLE 225            GCC COUNTRIES: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD BILLION)             253

TABLE 226            GCC COUNTRIES: HOME HEALTHCARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            253

TABLE 227            GCC COUNTRIES: HOME HEALTHCARE MARKET FOR THERAPEUTIC PRODUCTS,

BY TYPE, 2023–2030 (USD MILLION)         254

TABLE 228            GCC COUNTRIES: HOME HEALTHCARE MARKET FOR TESTING, SCREENING, AND MONITORING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)                255

TABLE 229            GCC COUNTRIES: HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 256

TABLE 230            GCC COUNTRIES: HOME HEALTHCARE SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            256

TABLE 231            GCC COUNTRIES: HOME HEALTHCARE INDICATIONS MARKET, BY TYPE,

2023–2030 (USD MILLION)            257

TABLE 232            HOME HEALTHCARE MARKET: OVERVIEW OF STRATEGIES ADOPTED

BY KEY PLAYERS, JANUARY 2022–JUNE 2025          259

TABLE 233            HOME HEALTHCARE MARKET: DEGREE OF COMPETITION, 2024 (%)               263

TABLE 234            HOME HEALTHCARE MARKET: REGION FOOTPRINT       269

TABLE 235            HOME HEALTHCARE MARKET: PRODUCT & SERVICE FOOTPRINT     270

TABLE 236            HOME HEALTHCARE MARKET: PRODUCT FOOTPRINT       270

TABLE 237            HOME HEALTHCARE MARKET: END-USER FOOTPRINT       271

TABLE 238            HOME HEALTHCARE MARKET: DETAILED LIST OF KEY STARTUPS/SMES              274

TABLE 239            HOME HEALTHCARE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2024                275

TABLE 240            HOME HEALTHCARE MARKET: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2022–JUNE 2025              276

TABLE 241            HOME HEALTHCARE MARKET: DEALS, JANUARY 2022–JUNE 2025              277

TABLE 242            HOME HEALTHCARE MARKET: EXPANSIONS, JANUARY 2022–JUNE 2025              279

TABLE 243            FRESENIUS MEDICAL CARE AG: COMPANY OVERVIEW          280

TABLE 244            FRESENIUS MEDICAL CARE AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED    281

TABLE 245            FRESENIUS MEDICAL CARE AG: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2022–JUNE 2025              282

TABLE 246            FRESENIUS MEDICAL CARE AG: DEALS, JANUARY 2022–JUNE 2025              283

TABLE 247            FRESENIUS MEDICAL CARE AG: EXPANSIONS, JANUARY 2022–JUNE 2025              283

TABLE 248            ABBOTT: COMPANY OVERVIEW                285

TABLE 249            ABBOTT: PRODUCTS/SOLUTIONS/SERVICES OFFERED             287

TABLE 250            ABBOTT: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025   288

TABLE 251            ABBOTT: DEALS, JANUARY 2022–JUNE 2025                 288

TABLE 252            ABBOTT: EXPANSIONS, JANUARY 2022–JUNE 2025        289

TABLE 253            LINDE PLC: COMPANY OVERVIEW           290

TABLE 254            LINDE PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED             291

TABLE 255            F. HOFFMANN-LA ROCHE LTD: COMPANY OVERVIEW          293

TABLE 256            F. HOFFMAN-LA ROCHE LTD: PRODUCTS/SOLUTIONS/SERVICES OFFERED    294

TABLE 257            F. HOFFMAN-LA ROCHE LTD: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2022–JUNE 2025              294

TABLE 258            RESMED: COMPANY OVERVIEW                296

TABLE 259            RESMED: PRODUCTS/SOLUTIONS/SERVICES OFFERED             297

TABLE 260            RESMED: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JUNE 2025   298

TABLE 261            RESMED: DEALS, JANUARY 2022–JUNE 2025                 299

TABLE 262            KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW          300

TABLE 263            KONINKLIJKE PHILIPS N.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    301

TABLE 264            KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2022–JUNE 2025              303

TABLE 265            KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022–JUNE 2025  304

TABLE 266            GE HEALTHCARE: COMPANY OVERVIEW                 305

TABLE 267            GE HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED    306

TABLE 268            GE HEALTHCARE: DEALS, JANUARY 2022–JUNE 2025        308

TABLE 269            A&D HOLON HOLDINGS COMPANY, LIMITED: COMPANY OVERVIEW   309

TABLE 270            A&D HOLON HOLDINGS COMPANY, LIMITED: PRODUCTS/SOLUTIONS/

SERVICES OFFERED        310

TABLE 271            CONVATEC GROUP PLC: COMPANY OVERVIEW                 312

TABLE 272            CONVATEC GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED    313

TABLE 273            CONVATEC GROUP PLC: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2022–JUNE 2025              314

TABLE 274            CONVATEC GROUP PLC: DEALS, JANUARY 2022–JUNE 2025             314

TABLE 275            CONVATEC GROUP PLC: EXPANSIONS, JANUARY 2022–JUNE 2025              315

TABLE 276            AMEDISYS: COMPANY OVERVIEW            316

TABLE 277            AMEDISYS: PRODUCTS/SOLUTIONS/SERVICES OFFERED             317

TABLE 278            AMEDISYS: DEALS, JANUARY 2022–JUNE 2025                 318

TABLE 279            OMRON HEALTHCARE CO., LTD.: COMPANY OVERVIEW          320

TABLE 280            OMRON HEALTHCARE CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    322

TABLE 281            OMRON HEALTHCARE CO., LTD.: DEALS, JANUARY 2022–JUNE 2025              324

TABLE 282            INVACARE CORPORATION: COMPANY OVERVIEW          325

TABLE 283            BAYADA HOME HEALTH CARE: COMPANY OVERVIEW          326

TABLE 284            DRIVE DEVILBISS HEALTHCARE: COMPANY OVERVIEW          327

TABLE 285            SUNRISE MEDICAL: COMPANY OVERVIEW                 328

TABLE 286            ROMA MEDICAL: COMPANY OVERVIEW                 330

TABLE 287            CAREMAX REHABILITATION EQUIPMENT CO., LTD.: COMPANY OVERVIEW       332

TABLE 288            VITALOGRAPH: COMPANY OVERVIEW  333

TABLE 289            ADVITA PFLEGEDIENST GMBH: COMPANY OVERVIEW          334

TABLE 290            THE RENAFAN GROUP: COMPANY OVERVIEW                 335

TABLE 291            CONTEC MEDICAL SYSTEMS CO., LTD.: COMPANY OVERVIEW   336

TABLE 292            B. BRAUN SE: COMPANY OVERVIEW       337

TABLE 293            BAXTER: COMPANY OVERVIEW 338

TABLE 294            MEDLINE INDUSTRIES: COMPANY OVERVIEW                 339

TABLE 295            ADVIN HEALTH CARE: COMPANY OVERVIEW                 340

LIST OF FIGURES

FIGURE 1              HOME HEALTHCARE MARKET SEGMENTATION AND REGIONAL SCOPE 29

FIGURE 2              HOME HEALTHCARE MARKET: RESEARCH DESIGN                32

FIGURE 3              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,

DESIGNATION, AND REGION     36

FIGURE 4              BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH              37

FIGURE 5              CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 38

FIGURE 6              HOME HEALTHCARE MARKET: TOP-DOWN APPROACH         39

FIGURE 7              DATA TRIANGULATION METHODOLOGY                 40

FIGURE 8              HOME HEALTHCARE MARKET: PARAMETRIC ASSUMPTIONS  41

FIGURE 9              HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE,

2025 VS. 2030 (USD BILLION)       43

FIGURE 10            HOME HEALTHCARE MARKET, BY PRODUCT, 2025 VS. 2030 (USD BILLION)       44

FIGURE 11            HOME HEALTHCARE MARKET, BY SERVICE, 2025 VS. 2030 (USD BILLION) 44

FIGURE 12            HOME HEALTHCARE MARKET, BY INDICATION, 2025 VS. 2030 (USD BILLION)       45

FIGURE 13            HOME HEALTHCARE MARKET: GEOGRAPHICAL SNAPSHOT          46

FIGURE 14            GROWING ELDERLY POPULATION AND HIGH INCIDENCE OF CHRONIC

DISEASES TO DRIVE MARKET     47

FIGURE 15            JAPAN TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD       48

FIGURE 16            ASIA PACIFIC TO LEAD MARKET DURING FORECAST PERIOD         49

FIGURE 17            DEVELOPED MARKETS TO HAVE LARGER SHARE DURING FORECAST PERIOD        50

FIGURE 18            HOME HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES          51

FIGURE 19            HOME HEALTHCARE MARKET: TRENDS AND DISRUPTIONS IMPACTING

CUSTOMER BUSINESS   59

FIGURE 20            HOME HEALTHCARE MARKET: VALUE CHAIN ANALYSIS            62

FIGURE 21            HOME HEALTHCARE MARKET: SUPPLY CHAIN ANALYSIS            63

FIGURE 22            HOME HEALTHCARE MARKET: ECOSYSTEM ANALYSIS            64

FIGURE 23            HOME HEALTHCARE MARKET: INVESTMENT AND FUNDING SCENARIO,

2020–2024              65

FIGURE 24            HOME HEALTHCARE MARKET: PATENT ANALYSIS,

JANUARY 2015–DECEMBER 2024 68

FIGURE 25            CANADA: APPROVAL PROCESS FOR MEDICAL DEVICES              74

FIGURE 26            EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES              75

FIGURE 27            HOME HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS           80

FIGURE 28            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF

HOME HEALTHCARE PRODUCTS              82

FIGURE 29            KEY BUYING CRITERIA FOR HOME HEALTHCARE PRODUCTS            83

FIGURE 30            AI USE CASES     85

FIGURE 31            ADJACENT MARKETS FOR HOME HEALTHCARE MARKET               86

FIGURE 32            NORTH AMERICA: HOME HEALTHCARE MARKET SNAPSHOT       160

FIGURE 33            ASIA PACIFIC: HOME HEALTHCARE MARKET SNAPSHOT          214

FIGURE 34            HOME HEALTHCARE MARKET: REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS, 2022–2024 (USD MILLION)                 262

FIGURE 35           HOME HEALTHCARE MARKET SHARE ANALYSIS, 2024 (%)                263

FIGURE 36            EV/EBITDA OF KEY VENDORS, 2025         265

FIGURE 37            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA

OF KEY VENDORS            265

FIGURE 38            HOME HEALTHCARE MARKET: BRAND/PRODUCT COMPARISON             266

FIGURE 39            HOME HEALTHCARE MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2024       267

FIGURE 40            HOME HEALTHCARE MARKET: COMPANY FOOTPRINT       268

FIGURE 41            HOME HEALTHCARE MARKET: COMPANY EVALUATION MATRIX

(STARTUPS/SMES), 2024                273

FIGURE 42            FRESENIUS MEDICAL CARE AG: COMPANY SNAPSHOT (2024)             281

FIGURE 43            ABBOTT: COMPANY SNAPSHOT (2024)  286

FIGURE 44            LINDE PLC: COMPANY SNAPSHOT (2024)                 291

FIGURE 45            F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT (2024)             293

FIGURE 46            RESMED: COMPANY SNAPSHOT (2024)   297

FIGURE 47            KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024)             301

FIGURE 48            GE HEALTHCARE: COMPANY SNAPSHOT (2024)                 306

FIGURE 49            A&D HOLON HOLDINGS COMPANY, LIMITED: COMPANY SNAPSHOT (2024)      310

FIGURE 50            CONVATEC GROUP PLC: COMPANY SNAPSHOT (2024)    313

FIGURE 51            AMEDISYS: COMPANY SNAPSHOT (2024)                 316

FIGURE 52            OMRON HEALTHCARE CO., LTD.: COMPANY SNAPSHOT (2024)             321

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧